Merit Medical Systems (MMSI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Mar, 2026Executive summary
Annual meeting scheduled for May 13, 2026, at 2:00 p.m. Mountain Time, to be held virtually.
Shareholders are encouraged to review proxy materials and vote by May 12, 2026, or May 8, 2026, for 401(k) plan shares.
Voting matters and shareholder proposals
Election of four directors: Martha G. Aronson (3-year term), Lonny J. Carpenter (3-year term), Lynne N. Ward (1-year term), Scott R. Ward (3-year term).
Advisory vote on executive compensation (say-on-pay) for named executive officers.
Approval of the 2026 Equity Incentive Plan.
Approval of the 2026 Employee Stock Purchase Plan.
Ratification of Deloitte & Touche LLP as independent auditor for the year ending December 31, 2026.
Proxies may vote on other business arising at the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Director terms vary, with three nominees for three-year terms and one for a one-year term.
Latest events from Merit Medical Systems
- Shareholders to vote on directors, pay, equity plans, and auditor amid record results and a CEO transition.MMSI
Proxy filing31 Mar 2026 - Double-digit 2025 growth and strong 2026 outlook, with risks from tariffs and divestitures.MMSI
Q4 202524 Feb 2026 - Strong 2025 growth, new leadership, and innovation drive global expansion and margin gains.MMSI
44th Annual J.P. Morgan Healthcare Conference24 Feb 2026 - Q2 2024 revenue and profit exceeded expectations, prompting raised full-year guidance.MMSI
Q2 20242 Feb 2026 - Raised guidance, strong cash flow, and strategic M&A drive growth and innovation.MMSI
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Rhapsody’s pivotal data and strong financials highlight a focus on growth and operational excellence.MMSI
Wells Fargo 2024 Healthcare Conference22 Jan 2026 - Wrapsody trial data, succession planning, and strong financials highlight growth and innovation.MMSI
Wells Fargo 2024 Healthcare Conference22 Jan 2026 - WRAPSODY’s clinical success and Q1 2025 approval target drive optimism for growth and margin gains.MMSI
CL King's 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 revenue up 7.8% and 2024 guidance raised on strong growth and acquisitions.MMSI
Q3 202417 Jan 2026